Subsequent studies extended these findings to genetic disorders like Ataxia–Telangiectasia, where gentamicin treatment of patient-derived lymphoblastoid cells led to the production of functional Ataxia Telangiectasia Mutated (ATM) protein [30]. The gene discussed is ATM; the disease is Ataxia-telangiectasia.